Covered recipient · General Payments record
AMELIA C GUZMAN BICCHI
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$1,611.93
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $581.99 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $216.08 | 6 |
| DEXCOM, INC. | $180.42 | 9 |
| Lilly USA, LLC | $118.73 | 1 |
| Acerta Pharma LLC | $66.76 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $23.49 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592106 | CMS |
| Amgen Inc. | $10.23 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592108 | CMS |
| Amgen Inc. | $23.81 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592110 | CMS |
| Amgen Inc. | $23.81 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592116 | CMS |
| Amgen Inc. | $26.79 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592112 | CMS |
| Amgen Inc. | $107.95 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592114 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.09 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105537195 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.97 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104559618 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.86 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105230936 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.84 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105367004 | CMS |
| Dexcom, Inc. | $4.88 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278439 | CMS |
| Dexcom, Inc. | $4.77 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278435 | CMS |
| Dexcom, Inc. | $9.72 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278437 | CMS |
| Dexcom, Inc. | $15.24 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278441 | CMS |
| Dexcom, Inc. | $8.96 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278443 | CMS |
| Dexcom, Inc. | $3.02 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278445 | CMS |
| Dexcom, Inc. | $121.20 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278451 | CMS |
| Dexcom, Inc. | $2.89 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278447 | CMS |
| Dexcom, Inc. | $9.74 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278449 | CMS |
| Lilly USA, LLC | $118.73 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136030508 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.